Medicus Pharma
MDCX
20 hedge funds and large institutions have $4.91M invested in Medicus Pharma in 2025 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 8 closing their positions.
5% less funds holding
Funds holding: 21 → 20 (-1)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
16.26% less ownership
Funds ownership: 16.26% → 0% (-16%)
26% less capital invested
Capital invested by funds: $6.6M → $4.91M (-$1.69M)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
YAG
Yorkville Advisors Global
Mountainside,
New Jersey
|
+$311K |
| 2 |
WSFS
Wilmington Savings Fund Society
Wilmington,
Delaware
|
+$64.3K |
| 3 |
BAM
Brave Asset Management
Summit,
New Jersey
|
+$50.2K |
| 4 |
LPL Financial
San Diego,
California
|
+$47K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$27.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIA
Guyasuta Investment Advisors
Pittsburgh,
Pennsylvania
|
-$230K |
| 2 |
Verition Fund Management
Greenwich,
Connecticut
|
-$160K |
| 3 |
SWM
SeaCrest Wealth Management
Purchase,
New York
|
-$139K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$123K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$60.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HF
26
HRT Financial
New York
| – | -$33K | -11,099 | Closed |
|
27
Raymond James Financial
St Petersburg,
Florida
| – | -$1.5K | -500 | Closed |
|
|
PFBT
28
Parkside Financial Bank & Trust
Saint Louis,
Missouri
| – | -$1.2K | -400 | Closed |
|
MDCX Hedge Fund Activity: Q3 2025 in Review
20 of the 7,631 institutional investors tracked by Wall St. Rank reported a position in Medicus Pharma (MDCX) for Q3 2025, worth a combined $4.91M — down 26% from $6.6M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of MDCX and 7 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 3 added.
The largest buyer was Yorkville Advisors Global, adding an estimated $311K. The largest seller was Guyasuta Investment Advisors, exiting entirely with an estimated $230K sold.
- 20 institutional investors held Medicus Pharma (MDCX) as of Q3 2025, down from 21 in Q2 2025.
- Funds reported $4.91M of Medicus Pharma stock for Q3 2025, down 26% quarter-over-quarter.
- 7 funds opened new Medicus Pharma positions in Q3 2025 and 8 closed out, a net change of -1 holder.
- The largest Medicus Pharma buyer in Q3 2025 was Yorkville Advisors Global, an estimated $311K added.
- The largest Medicus Pharma seller in Q3 2025 was Guyasuta Investment Advisors, an estimated $230K sold.
Based on aggregated 13F filings for Q3 2025.